180 Life Sciences Corp. Files 8-K on Equity Sales
Ticker: FRMM · Form: 8-K · Filed: Jun 20, 2025 · CIK: 1690080
| Field | Detail |
|---|---|
| Company | 180 Life Sciences CORP. (FRMM) |
| Form Type | 8-K |
| Filed Date | Jun 20, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: equity-sale, 8-K, corporate-event
TL;DR
180 Life Sciences filed an 8-K detailing unregistered equity sales and other events on June 17, 2025.
AI Summary
On June 17, 2025, 180 Life Sciences Corp. reported on the unregistered sale of equity securities and other events. The company, formerly known as KBL Merger Corp. IV, is incorporated in Delaware and its fiscal year ends on December 31st. The filing details transactions related to its common stock and warrants.
Why It Matters
This filing provides insight into recent equity transactions by 180 Life Sciences Corp., which could impact its capital structure and shareholder value.
Risk Assessment
Risk Level: medium — Filings related to unregistered sales of equity securities can indicate potential dilution or financing activities that may affect stock value.
Key Players & Entities
- 180 Life Sciences Corp. (company) — Registrant
- KBL Merger Corp. IV (company) — Former company name
- June 17, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
FAQ
What specific type of equity securities were sold unregistered?
The filing mentions 'Unregistered Sales of Equity Securities' as an item, but the specific details of the securities sold are not elaborated in the provided text.
What are the 'Other Events' reported in this 8-K filing?
The filing lists 'Other Events' as a reported item, but the nature of these events is not detailed in the provided text.
When was the company formerly known as KBL Merger Corp. IV?
The company was formerly known as KBL Merger Corp. IV, with a date of name change indicated as November 15, 2016.
What is the primary business of 180 Life Sciences Corp. according to the SIC code?
According to the Standard Industrial Classification (SIC) code provided, 180 Life Sciences Corp. is in the 'PHARMACEUTICAL PREPARATIONS' industry, with code 2834.
What is the fiscal year end for 180 Life Sciences Corp.?
The fiscal year end for 180 Life Sciences Corp. is December 31st.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 regarding 180 Life Sciences Corp. (FRMM).